Profile of soluble factors in pleural effusions predict prognosis in mesothelioma.

Dick, I M; Lee, Y C G; Cheah, H M; Miranda, A; Robinson, B W S; Creaney, J

Dick, I M; Lee, Y C G; Cheah, H M; Miranda, A; Robinson, B W S; Creaney, J.

Afiliação

Dick IM; National Centre for Asbestos Related Disease, University of Western Australia, Nedlands, WA, Australia.
Lee YCG; Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia.
Cheah HM; Institute of Respiratory Health, University of Western Australia, Nedlands, WA, Australia.
Miranda A; Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia.
Robinson BWS; Institute of Respiratory Health, University of Western Australia, Nedlands, WA, Australia.
Creaney J; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

Cancer Biomark ; 33(1): 159-169, 2022.

Article em En | MEDLINE | ID: mdl-34487023

Assuntos

Neoplasias Pulmonares; Mesotelioma; Derrame Pleural Maligno; Derrame Pleural; Neoplasias Pleurais; Biomarcadores Tumorais/metabolismo; Humanos; Neoplasias Pulmonares/metabolismo; Mesotelioma/diagnóstico; Mesotelioma/metabolismo; Derrame Pleural/diagnóstico; Derrame Pleural Maligno/diagnóstico; Neoplasias Pleurais/diagnóstico; Prognóstico

Palavras-chave

Pleural mesothelioma; cellular factors; chemokines; cytokines; pleural effusions; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Derrame Pleural / Neoplasias Pleurais / Derrame Pleural Maligno / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Biomark Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google